• 생약학회지
• /
• 제32권4호통권127호
• /
• pp.257-268
• /
• 2001

Analgesic and antiinflammatory activities of several herbal medicines were investigated in order to develop the antiinflammatory drugs from oriental herbal medicines. 80% Ethanol extracts of Ephedra sinica, Chaenoleles sinensis, Asiasarum siboldi, Nelumbo nucifera, Scolopendra subspinipes mutians, Evodia officinalis, Aremarrhenae asphodeloides, Bufo bufo gargarizans, Gardenia jasminoides, Piper longum, Carthamus tinctorius, Piperus nigrum, Magnolia officinalis and Siegesbeckia glabrescens showed significant inhibitory effects on hyaluronidase, trypsin, and albumin denaturation in vitro. They also decreased the acetic acid-induced pain and vascular permeability induced by histamine in mice.

• 한국작물학회:학술대회논문집
• /
• 한국작물학회 2006년도 한국약용작물학회 공동춘계학술발표회
• /
• pp.524-525
• /
• 2006

• 생약학회지
• /
• 제29권3호
• /
• pp.237-242
• /
• 1998

We have tested tyrosinase inhibitory activity on the methanol extracts of 23 species marine algae and 23 species traditional medicinal plant. Among them, four medicinal plants, Ephedra sinica, Atractylodes japonica, Pinnelia ternata, and Citrus aurantium, showed strong inhibition potency over 90% at concentration of 0.33 mg/mL. Also, two marine algae, Enteromorpha compressa and Sargassum singgildianum showed mild inhibition potency over 50% at concentration of 0.33 mg/mL.

• 약학회지
• /
• 제39권1호
• /
• pp.1-5
• /
• 1995

As a continuation of the previous study, a second group of sixty two aqueous extracts(freeze dried) from natural products was screened for the inhibitory effect of platelet activating factor(PAF) binding to rabbit platelet using 0.6 nM [$^{3}$H]PAF as a radioligand. The results demonstrated that three medicinal plants inhibited 40~50% of [$^{3}$H]PAF equilibrium binding at the concentration of 200 $\mu\textrm{g}$/ml.

• 생약학회지
• /
• 제28권4호
• /
• pp.167-173
• /
• 1997

We have tested 101 species traditional medicinal plants on Acetylcholinester ase inhibition. Among them. Caesalpina sappan. Cnidium offcinale, Coptis japonica, Ephedra sinica, Eribotrya japonica, Gardenia jasminoides, Liriope platyphylla, Lonicera japonica, Paeonia suffruticosa, Phyllostachys nigra, Polygonum multiflorum, Prunella vulgaris, Rheum undulatum, Salvia miltiorrhiza and Uncaria rhynchophylla showed strong inhibition potency over 88%. In addition, Aconitum carmichaeli, Caesalphina sappan, Cinnamomun japonica, Citrus unshiu, Hordeum vulgare, Glycine max and Rehmannia glutinosa showed relatively good inhibition potency over 80%.

• 대한화장품학회지
• /
• 제35권3호
• /
• pp.229-233
• /
• 2009

식물 20종을 메탄올로 추출하여 양성자 빔 조사 에너지양(1, 5, 10 KGray)에 따른 항산화 활성 능을 탐색 하고자 DPPH 라디칼 소거활성과 ABTS free 라디칼 소거 활성에 대하여 조사하였다. 양성자 빔 조사 시 15종류는 활성이 증가하였으나 10 KGray에서 흑축(Pharbitis nil Choisy)은 활성이 감소하였으며, 4종류는 활성변화가 없었다. DPPH 라디칼 소거활성은 1 및 5 KGray에서 유근피(Ulmus macrocarpa) (84 %), 10 KGray (85 %)로 가장 높았으나 10 KGray에서 흑축(Pharbitis nil Choisy)은 6 % 감소하였다. $IC_{50}$값을 무처리구와 빔 조사량에 대한 활성을 비교하면 1 KGray에서 산약(Dioscorea batatas Decne.) 6.3배, 5 KGray에서 천화분(Trichosanthes kirilowii Max.) 2.1배, 산약(Dioscorea batatas Decne.) 2.8배 증가하였다. ABTS free 라디칼 소거활성에서 1 KGray의 양성자 빔 에너지를 조사 했을 경우, 가자(Terminalia chebula Retzius)는 60 % 증가하였다. $IC_{50}$값은 1 KGray 빔 조사 시 0 KGray보다 마황근(Ephedra sinica Stapf) 2.0배, 가자(Terminalia chebula Retz.) 2.5배, 우방자(Arctium lappa Linne) 2.4배 증가하였다.

• 한국약용작물학회지
• /
• 제11권1호
• /
• pp.24-30
• /
• 2003

11종의 약리식물의 수용성 추출물에서 세포독성능과 TGEV와 PEDV에 대한 항바이러스 효능을 분석하였다. 이들 추출물은 바이러스의 숙주세포로 사용되는 ST세포와 Vero세포에 대해 다른 세포독성능을 나타내었는데, 오가피 추출물은 TGEV에 대한 숙주세포주인 ST 세포에 대해 75.81 %의 세포독성을 나타내었으며, 화살나무, 무화과나무, 까마종이, 마황, 창이자 추출물은 20-50% 사이의 세포독성을 나타내었다. 그러나 마황 추출물(35.66%) 이외의 10종의 추출물은 PEDV에 대한 숙주세포주인 Vero 세포에 대해 세포독성능을 나타내지 않았다. 세포독성이 낮은 식물추출물에서 초피나무, 구지뽕나무, 누리장나무, 고삼 추출물이 TGEV에 대하여 효과적인 항바이러스능을 나타내었으며, PEDV에 대하여는 초피나무, 조각자나무, 고삼, 까마종이, 마황 추출물에서 효과적인 항바이러스능을 나타내었다. 이중에서 고삼과 초피나무 추출물은 TGEV와 PEDV에 대해서 효과적인 항바이러스능을 나타내었다.

• 한방비만학회지
• /
• 제11권1호
• /
• pp.47-60
• /
• 2011

Objectives The objective of this study was to contribute to the development of pharmacupuncture for obesity treatment by reviewing the studies of pharmacupuncture experimentations and clinical trials. Methods We searched the papers with keywords of 'obesity' and 'pharmacupuncture' in the search site, RISS, Oriental medicine advanced searching integrated system(OASIS), Korean traditional knowledge portal, the society of Korean medicine for obesity research, Korean pharmacupuncture institute, the Korean academy of oriental rehabitation medicine and Korean acupuncture & moxibustion society. Results 1. We reviewed 37 articles searched. 27 articles(73.0%) were animal experimentations, 5 articles(13.5%) were cell experimentations, 4 articles(10.8%) were clinical trials and 1 article(2.7%) was study analysis. 2. The herbs, using for animal experimentations, were atratylodes japonica, coix lachrymajobi, ephedra sinica, crataegus pinnatifida, wild ginseng and etc. Acupucture points were joksamni(ST36), zhongwan(CV12), gansoo(BL18), pungnyung(ST40), umnungchon(SP9), bisu(BL20), gokji (LI11), cheun-chu(ST25) and etc. 3. For cell experimentations, preadipocytes and adipocytes performed on cell cultures with using rats, 3T3-L1 preadipocytes and porcine skin including fat tissue were treated with fel ursi, bovis calculus, ephedrae herba, spirodelae herba, wild ginseng. 4. For clinical trials, Sangsik no.1, Bigiheo, ephedra, green tea and sweet bee venom were injected at the region where a lot of fat like zhongwan(CV12), xiawan(CV10), kwanwon(CV4), cheun-chu(ST25) and thigh. Conclusion Through animal and cell experimentations and clinical trials, the treatment of obesity using local acupuncture therapy was effective. For clinical use, however, it is considered that animal and cell experimentation and clinical trial's connection using one kind of herb and studies about more clinical trials and associated side effects are needed.

• 대한한의학회지
• /
• 제22권3호
• /
• pp.74-80
• /
• 2001

Objectives : Ma-huang is a traditional Chinese medicinal herb, derived from Ephedra sinica Stapf and other Ephedra species, used to treat asthma, nose and lung congestion, and fever with anhidrosis. It contains 0.5-2.5% by weight of total alkaloids, of which ephedrine accounts for 30 to 90%. Recently, Ma-huang has been used as a source of ephedrine in many dietary supplements formulated for the treatment of obesity, since ephedrine has been found to be effective in inducing weight loss in the obese. In this study the effects of the methanol extract of Ma-huang on the adipocyte of epididymal and brown fat pads in rats fed a high fat diet for six weeks were studied. Methods : Male Sprague Dawley rats weighing an average 94g (4 weeks old) were fed either a regular diet (RE) or a high fat diet (HF), and the HF group was subdivided into a Ma-huang methanol extract (30mg/100g body weight) group (HF+MH). The weight of epididymal fat pad and brown adipose tissue were measured. The cell size and cell number per unit area of epididymal fat pad were investigated. Results : The yield weight of methanol extract of Ma-huang was 3.63mg per l00g of Ma-huang. The body weight gain of the HF group was similar with that of the HF+ MH but higher than that of the RE. The weights of the epididymal fat pads and brown adipose tissue of the RE group were lower than those of HF and HF+MH groups. The cell sizes and numbers per unit area of epididymal fat pads of the RE and HF+MH groups were larger than those of HF group. The cell numbers per unit area size of epididymal fat pads were the smallest in the RE group. Conclusions : It could be concluded that the Ma-huang extract has no effect on the epididymal fat pads in rats fed a high fat diet and the clinical application of Ma-huang for the treatment of obesity should be re-considered.

• 대한한방내과학회지
• /
• 제27권1호
• /
• pp.188-196
• /
• 2006

Background: Ma-huang (Ephedra sinica) has been widely used to treat respiratory disease in oriental medicine for over a hundred years. Ma-huang preparations contain approximately 1.25% ephedrine alkaloids. Recently, the ephedra alkaloids have received much press lately due to adverse effects in those using whole extracts as 'dietary supplements' for weight loss or athletic performance enhancement, and these reports are troubling given the increasing use of Ma-huang by the general public. The purpose of this report is to determine the proper dosage to minimize adverse effects and maximize the potential curative value. Objectives : The object of this study was to find an effective yet low risk dosage of Ma-huang. Methods : The study was designed as a double-blind randomized placebo-controlled trial. The subjects of this study were 26 adults between 20 to 40 of age who agreed to participate in this study. They were allocated through randomization into three groups. Each group took three opaque capsules three times a day. A group (N=9) took one Ma-huang capsule and two placebo capsules, B group (N=8) took two Ma-huang capsules and one placebo capsule, C group (N=9) took three Ma-huang capsules. The total trial periods was two days. To compare the adverse effects of Ma-huang according to dosage, blood pressure and pulse were checked, and other adverse effects were assessed using a morning questionnaire, patient's global assessment scale and Wong-Baker faces pain rating. Results : The following result were obtained: 1. After taking 18 g of Ma-huang per day, pulse rate had a significant increase. 2. After taking more than 6 g of Ma-huang per day, palpitation would be increased significantly. 3. After taking more than 18 g of Ma-huang per day, tiredness would be increased significantly. Conclusion: According to the results, 12 g of Ma-huang per day will minimize adverse effects and maximize the potential curative value.